Targeted mutation detection in breast cancer using MammaSeq™

BACKGROUND: Breast cancer is the most common invasive cancer among women worldwide. Next-generation sequencing (NGS) has revolutionized the study of cancer across research labs around the globe; however, genomic testing in clinical settings remains limited. Advances in sequencing reliability, pipeli...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Nicholas G., Gyanchandani, Rekha, Shah, Osama S., Gurda, Grzegorz T., Lucas, Peter C., Hartmaier, Ryan J., Brufsky, Adam M., Puhalla, Shannon, Bahreini, Amir, Kota, Karthik, Wald, Abigail I., Nikiforov, Yuri E., Nikiforova, Marina N., Oesterreich, Steffi, Lee, Adrian V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368740/
https://www.ncbi.nlm.nih.gov/pubmed/30736836
http://dx.doi.org/10.1186/s13058-019-1102-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368740/
https://www.ncbi.nlm.nih.gov/pubmed/30736836
http://dx.doi.org/10.1186/s13058-019-1102-7

Ejemplares similares